BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23189988)

  • 1. PPAR-γ agonistic metabolites from the ascidian Herdmania momus.
    Li JL; Xiao B; Park M; Yoo ES; Shin S; Hong J; Chung HY; Kim HS; Jung JH
    J Nat Prod; 2012 Dec; 75(12):2082-7. PubMed ID: 23189988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design, synthesis, and PPARalpha/gamma agonistic activity of novel tetrahydroisoquinoline derivatives].
    Yu R; Zhou YL; Huan Y; Liu Q; Shen ZF; Liu ZZ
    Yao Xue Xue Bao; 2011 Mar; 46(3):311-6. PubMed ID: 21626786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists.
    Xiao B; Yin J; Park M; Liu J; Li JL; Kim EL; Hong J; Chung HY; Jung JH
    Bioorg Med Chem; 2012 Aug; 20(16):4954-61. PubMed ID: 22819190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peroxisome proliferator-activated receptor-gamma agonist and other constituents from Chromolaena odorata.
    Dat NT; Lee K; Hong YS; Kim YH; Minh CV; Lee JJ
    Planta Med; 2009 Jun; 75(8):803-7. PubMed ID: 19242902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius.
    Tapiolas DM; Bowden BF; Abou-Mansour E; Willis RH; Doyle JR; Muirhead AN; Liptrot C; Llewellyn LE; Wolff CW; Wright AD; Motti CA
    J Nat Prod; 2009 Jun; 72(6):1115-20. PubMed ID: 19505081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes.
    Hong SS; Lee JH; Jeong W; Kim N; Jin HZ; Hwang BY; Lee HJ; Lee SJ; Jang DS; Lee D
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2347-9. PubMed ID: 22342624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
    Madhavan GR; Chakrabarti R; Reddy KA; Rajesh BM; Balraju V; Rao PB; Rajagopalan R; Iqbal J
    Bioorg Med Chem; 2006 Jan; 14(2):584-91. PubMed ID: 16198573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory amino acid derivatives from the ascidian Herdmania momus.
    Li JL; Han SC; Yoo ES; Shin S; Hong J; Cui Z; Li H; Jung JH
    J Nat Prod; 2011 Aug; 74(8):1792-7. PubMed ID: 21770369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
    Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design, synthesis, and PPARgamma agonistic activity of novel indenone derivatives].
    Qu LL; Ma YH
    Yao Xue Xue Bao; 2013 Apr; 48(4):508-13. PubMed ID: 23833937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design, synthesis and antidiabetic activity of novel tetrahydrocarboline PPAR regulators].
    Peng K; Huan Y; Liu Q; Shen ZF; Liu ZZ
    Yao Xue Xue Bao; 2014 Apr; 49(4):490-6. PubMed ID: 24974466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone.
    Seto S; Okada K; Kiyota K; Isogai S; Iwago M; Shinozaki T; Kitamura Y; Kohno Y; Murakami K
    J Med Chem; 2010 Jul; 53(13):5012-24. PubMed ID: 20527969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epimeric methylsulfinyladenosine derivatives from the marine ascidian Herdmania momus.
    Li JL; Kim EL; Wang H; Hong J; Shin S; Lee CK; Jung JH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4701-4. PubMed ID: 23810281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma.
    Hiep NT; Choi YH; Kim N; Hong SS; Hong SB; Hwang BY; Lee HJ; Lee SJ; Jang DS; Lee D
    J Nat Prod; 2012 Apr; 75(4):784-8. PubMed ID: 22424300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of phenyloxyisobutyric acid derivatives and their antidiabetic activity in vitro].
    Zeng QL; Wang HQ; Luo H; Gao XP; Liu ZR; Li BG; Wang FP; Zhao YF
    Yao Xue Xue Bao; 2006 Feb; 41(2):108-14. PubMed ID: 16671538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
    Gani OA; Sylte I
    Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes.
    Uchiyama M; Koda H; Fischer T; Mueller J; Yamamura N; Oguchi M; Iwabuchi H; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 Jul; 39(7):1311-9. PubMed ID: 21511943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.